Skip to main content

Applied Genetic Technologies Corp

AGTCDelisted Dec 1, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001273636

Applied Genetic Technologies Corp was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Dec 1, 2022; 45 institutions reported holding it in 13F filings for Q3 2022, worth $3.34M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Applied Genetic Technologies Corp changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of AGTC: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders6455−9
Shares13.1M11.8M−1.29M (−9.9%)
Value$38.9M$22.4M−$16.4M (−42.3%)

New holders (9)

Institutions that held Applied Genetic Technologies Corp at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to AGTC in Q4 2021
InstitutionSharesValue% of portfolio
Kestra Advisory Services, LLC28,000$53.0K0.00%
XTX Topco Ltd17,606$33.0K0.02%
Two Sigma Securities, LLC15,282$29.0K0.01%
Aquatic Capital Management LLC12,341$23.0K0.04%
Commonwealth Equity Services, LLC10,614$20.0K0.00%
Simplex Trading, LLC4,586$8.00K0.00%
Royal Bank of Canada2,621$5.00K0.00%
Federated Hermes, Inc.1,917$4.00K0.00%
National Bank of Canada1,700$3.00K0.00%

Sold out (18)

Institutions that held Applied Genetic Technologies Corp at the end of Q3 2021 and filed for Q4 2021 without it.